semaglutide and mcas Mechanism of in MASLD Treatment: Where Is the Master Key? - Ezhilarasan - 2025 - Journal of Gastroenterology Hepatology Microdosing GLP-1 Medications for MCAS

24 Here we demonstrate that both of these obstacles are surmountable by using a 1 H-MRS editing method to measure CNS GSH levels, and a noninvasive (in)GSH administration strategy

Annals of Hepatology

Preclinical research shows that GIP signaling: Promotes neuronal survival and reduces apoptosis (cell death) in the hippocampus, a brain region involved in pain memory and emotional processing of pain Enhances synaptic plasticity and BDNF expression, both of which are reduced in fibromyalgia Reduces oxidative stress in neural tissue by upregulating antioxidant enzymes These GIP-specific neuroprotective effects aren't available from GLP-1-only medications, giving tirzepatide a theoretical advantage for conditions involving neural dysfunction

Manage New Patient Enrollments with Caution : New patients, particularly those seeking Ozempic for weight loss (a non-FDA-approved use), should be enrolled cautiously